Wells Fargo & Company MN raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 24.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 855,877 shares of the medical instruments supplier’s stock after acquiring an additional 169,844 shares during the quarter. Wells Fargo & Company MN owned approximately 0.37% of DENTSPLY SIRONA worth $55,496,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in XRAY. Russell Investments Group Ltd. boosted its position in shares of DENTSPLY SIRONA by 20.6% during the 1st quarter. Russell Investments Group Ltd. now owns 158,817 shares of the medical instruments supplier’s stock worth $9,920,000 after acquiring an additional 27,145 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of DENTSPLY SIRONA by 109.6% during the 1st quarter. Canada Pension Plan Investment Board now owns 25,993 shares of the medical instruments supplier’s stock worth $1,623,000 after acquiring an additional 13,593 shares in the last quarter. Comerica Bank boosted its position in shares of DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 60,531 shares of the medical instruments supplier’s stock worth $3,842,000 after acquiring an additional 1,734 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of DENTSPLY SIRONA by 4.1% during the 1st quarter. UBS Asset Management Americas Inc. now owns 1,024,996 shares of the medical instruments supplier’s stock worth $64,001,000 after acquiring an additional 40,816 shares in the last quarter. Finally, Commerce Bank boosted its position in shares of DENTSPLY SIRONA by 1.6% during the 1st quarter. Commerce Bank now owns 14,029 shares of the medical instruments supplier’s stock worth $876,000 after acquiring an additional 220 shares in the last quarter. 93.97% of the stock is owned by institutional investors and hedge funds.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 59.34 on Friday. DENTSPLY SIRONA Inc. has a 1-year low of $52.54 and a 1-year high of $65.68. The firm’s 50-day moving average price is $57.21 and its 200 day moving average price is $61.78. The stock’s market capitalization is $13.62 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same period in the previous year, the firm posted $0.76 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. Analysts expect that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.59%. DENTSPLY SIRONA’s payout ratio is currently -10.09%.

COPYRIGHT VIOLATION WARNING: “Wells Fargo & Company MN Has $55.50 Million Stake in DENTSPLY SIRONA Inc. (XRAY)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/17/wells-fargo-company-mn-has-55-50-million-stake-in-dentsply-sirona-inc-xray.html.

Several research analysts have recently issued reports on the company. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. HC Wainwright reaffirmed a “buy” rating and set a $68.00 price objective (down from $74.00) on shares of DENTSPLY SIRONA in a research report on Monday, August 14th. Morgan Stanley upped their target price on DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Thursday, August 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a research report on Thursday, July 13th. Finally, TheStreet cut DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $65.73.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.